Gelbard Christina M, Epstein Hayley, Hebert Adelaide
Department of Dermatology, University of Texas-Houston, Houston, Texas 77004, USA.
Pediatr Dermatol. 2008 Nov-Dec;25(6):591-8. doi: 10.1111/j.1525-1470.2008.00782.x.
Hyperhidrosis is a disorder of excessive sweating beyond what is physiologically necessary for thermoregulation. Primary hyperhidrosis is localized; it can affect the axillae, palms, soles, face, and other areas and is idiopathic. The prevalence of hyperhidrosis in the United States is estimated to be 2.8% of the population, with about one-half (1.4%) of these individuals having the axillary form. Hyperhidrosis occurs in both children and adults, with the average age of onset of primary hyperhidrosis being 14-25 years. This disorder can be detrimental to a patient's social, professional, psychological, and physical well-being. Early detection and management can significantly improve a patient's quality of life, yet hyperhidrosis remains widely under diagnosed and under treated, particularly among pediatric patients. The purpose of this article is to review the treatment of pediatric hyperhidrosis, and to increase awareness and inspire further research on this important and often overlooked medical problem.
多汗症是一种出汗过多的病症,超出了体温调节生理所需的范围。原发性多汗症是局部性的;它可影响腋窝、手掌、脚底、面部和其他部位,且病因不明。据估计,美国多汗症的患病率为人口的2.8%,其中约一半(1.4%)的人患有腋窝型多汗症。多汗症在儿童和成人中均有发生,原发性多汗症的平均发病年龄为14至25岁。这种病症会对患者的社交、职业、心理和身体健康造成损害。早期发现和治疗可显著提高患者的生活质量,但多汗症仍普遍诊断不足和治疗不足,尤其是在儿科患者中。本文的目的是综述儿科多汗症的治疗方法,并提高人们对这一重要且常被忽视的医学问题的认识,激发进一步的研究。